Â¥
7.06
Jun 6
New Key Statistics Module, Z-Score and F-Score
SZSE:002365 Key Ratios
Market Cap ¥ M | 2,080.46 |
Enterprise Value ¥ M | 1,253.34 |
P/E(ttm) | 1,765.00 |
PE Ratio without NRI | 62.48 |
Forward PE Ratio | -- |
Price/Book | 1.03 |
Price/Sales | 2.36 |
Price/Free Cash Flow | 40.66 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.88 |
Revenue (TTM) ¥ M | 858.00 |
EPS (TTM) ¥ | 0.004 |
Beneish M-Score | -2.45 |
10-y EBITDA Growth Rate % | 13.80 |
5-y EBITDA Growth Rate % | -8.70 |
y-y EBITDA Growth Rate % | -74.90 |
EV-to-EBIT | 49.69 |
EV-to-EBITDA | 49.69 |
PEG | -- |
Shares Outstanding M | 294.68 |
Net Margin (%) | 0.16 |
Operating Margin % | 3.22 |
Pre-tax Margin (%) | 2.89 |
Quick Ratio | 5.04 |
Current Ratio | 5.39 |
ROA % (ttm) | 0.06 |
ROE % (ttm) | 0.07 |
ROIC % (ttm) | -1.19 |
Dividend Yield % | 1.37 |
Altman Z-Score | 6.91 |
SZSE:002365 Number of Guru Trades
SZSE:002365 Volume of Guru Trades
Gurus Latest Trades with SZSE:002365
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002365 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Qianjiang Yongan Pharmaceutical Co Ltd Insider Transactions
No Available Data